Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcturus Therapeutics Holdings (ARCT) Other Non Operating Income (2018 - 2025)

Arcturus Therapeutics Holdings' Other Non Operating Income history spans 8 years, with the latest figure at $10.4 million for Q4 2025.

  • For Q4 2025, Other Non Operating Income rose 224.02% year-over-year to $10.4 million; the TTM value through Dec 2025 reached $19.0 million, up 185.89%, while the annual FY2025 figure was $10.1 million, 33.56% down from the prior year.
  • Other Non Operating Income reached $10.4 million in Q4 2025 per ARCT's latest filing, up from $3.2 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $10.4 million in Q4 2025 to a low of -$34.2 million in Q4 2023.
  • Average Other Non Operating Income over 5 years is $77200.0, with a median of $1.4 million recorded in 2022.
  • Peak YoY movement for Other Non Operating Income: surged 9104.55% in 2021, then plummeted 4135.66% in 2023.
  • A 5-year view of Other Non Operating Income shows it stood at $2.0 million in 2021, then tumbled by 57.24% to $847000.0 in 2022, then tumbled by 4135.66% to -$34.2 million in 2023, then skyrocketed by 109.4% to $3.2 million in 2024, then surged by 224.02% to $10.4 million in 2025.
  • Per Business Quant, the three most recent readings for ARCT's Other Non Operating Income are $10.4 million (Q4 2025), $3.2 million (Q3 2025), and $2.6 million (Q2 2025).